SC 13G: Nuo Therapeutics, Inc.

Ticker: AURX · Form: SC 13G · Filed: Feb 14, 2024 · CIK: 1091596

Nuo Therapeutics, Inc. SC 13G Filing Summary
FieldDetail
CompanyNuo Therapeutics, Inc. (AURX)
Form TypeSC 13G
Filed DateFeb 14, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: sc-13g

AI Summary

SC 13G filing by Nuo Therapeutics, Inc..

Risk Assessment

Risk Level: low

FAQ

What type of filing is this?

This is a SC 13G filing submitted by Nuo Therapeutics, Inc. (ticker: AURX) to the SEC on Feb 14, 2024.

What is the risk level of this SC 13G filing?

This filing has been assessed as low risk.

What are the key financial figures in this filing?

Key dollar amounts include: $0.0001 (INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o).

How long is this filing?

Nuo Therapeutics, Inc.'s SC 13G filing is 2 pages with approximately 664 words. Estimated reading time is 3 minutes.

Where can I view the full SC 13G filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 664 words · 3 min read · ~2 pages · Grade level 9.2 · Accepted 2024-02-14 13:58:57

Key Financial Figures

  • $0.0001 — INC. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class o

Filing Documents

(a). Name of issuer

Item 1(a). Name of issuer: Nuo Therapeutics, Inc. (the " Issuer " )

(b). Address of issuer's principal executive offices

Item 1(b). Address of issuer's principal executive offices: 8285 El Rio, Suite 190 Houston TX 77054

(a). Name of person filing

Item 2(a). Name of person filing: This Schedule 13G is being filed by Paul Anthony Jacobs (the " Reporting Person " ).

(b). Address of principal business office or, if none, residence

Item 2(b). Address of principal business office or, if none, residence: The residence address of the Reporting Person is 5434 E. Lincoln Drive, Colonia Miramonte #28, Paradise Valley, AZ 85253. .

(c). Citizenship

Item 2(c). Citizenship: The Reporting Person is a citizen of the United States.

(d). Title of Class of Securities

Item 2(d). Title of Class of Securities: Common Stock, $0.0001 par value per share ( " Common Stock " )

(e). CUSIP No

Item 2(e). CUSIP No.: 67059V209 Item 3. Not Applicable.

Ownership

Item 4. Ownership The Reporting Person beneficially owns 2,250,000 shares in the Paul Anthony Jacobs and Nancy E. Jacobs Joint Trust and 250,000 shares in the P. Anthony Jacobs IRA.

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class Not Applicable.

Ownership of More Than Five Percent on Behalf of Another Person

Item 6. Ownership of More Than Five Percent on Behalf of Another Person Not Applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person Not Applicable.

Identification and Classification of Members of the Group

Item 8. Identification and Classification of Members of the Group Not Applicable.

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group Not Applicable.

Certification

Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a – 11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 14, 2024 By: /s/ Paul Anthony Jacobs Name: Paul Anthony Jacobs Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

View Full Filing

View this SC 13G filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.